HPV status in sentinel nodes might be a prognostic factor in cervical cancer

Gynecologic Oncology

Volumn 105, Issue 2, 2007, Pages 351-357

  Lee, Yong Seok ^a   Rhim, Chae Chun ^b   Lee, Hae Nam ^a   Lee, Keun Ho ^a   Park, Jong Sup ^a   Namkoong, Sung Eun ^a  

^a The Catholic University of Korea   (South Korea)

^b Hallym University Medical Center   (South Korea)

Author keywords

Cervical cancer; HPV; Metastasis; Recurrence; Sentinel node

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; DNA MICROARRAY; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; FROZEN SECTION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AGED; DNA, VIRAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENTINEL LYMPH NODE BIOPSY; UTERINE CERVICAL NEOPLASMS;

EID: 34247120153     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.12.016     Document Type: Article

References (31)

1. Morton D.L., Thompson J.F., Essner R., Elashoff R., Stern S.L., Nieweg O.E., et al. Validation of accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann. Surg. 4 (1999) 453-463
2. Veronesi U., Paganelli G., Galimberti V., Viale G., Zurrida S., Bedoni M., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
3. de Hullu J.A., Oonk M.H.M., Ansink A.C., Hollema H., Jager P.L., and van der Zee A.G.J. Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol. Oncol. 94 (2004) 10-14
4. Alvaro P.P., Nicolas F.S., Javier P., Jane K., Eduardo L.F., Christopher P.C., et al. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecol. Oncol. 92 (2004) 856-865
5. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 (2002) 244-265
6. Franco E.L., Duarte-Franco E., and Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 164 (2001) 1017-1025
7. Stoler M.H. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int. J. Gynecol. Pathol. 19 (2000) 16-28
8. Liss J., Emerich J., Lukaszuk K., Zwalinski M., and Wojcikowski C. The use of PCR technique in the evaluation of the frequency of HPV infection in vulvar and cervical carcinoma. Ginekol. Pol. 69 (1998) 330-334
9. Park J.S., Rhyu K.S., Kim C.J., Kim H.S., Han K.T., Ahn H.K., et al. Presence of oncogenic HPV DNAs in cervical carcinoma tissues and pelvic lymph nodes associated with proliferating cell nuclear antigen expression. Gynecol. Oncol. 60 (1996) 418-423
10. Baay M.F., Koudstaal J., Hollema H., Duk J.M., Burger M.P., Quint W.G., et al. Detection of HPV-16 DNA by PCR in histologically cancer free lymph nodes from patients with cervical cancer. J. Clin. Pathol. 50 (1997) 960-961
11. Grisaru D.A., Covens A., Franssen E., Chapman W., Shaw P., Colgan T., et al. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma. Cancer 97 (2003) 1904-1908
12. Morice P., Castaigne D., Pautier P., Rey A., Haie-Meder C., Leblanc M., et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol. Oncol. 73 (1999) 106-110
13. Comerci G., Bolger B.S., Flannelly G., Maini M., de Barros Lopes A., and Monaghan J.M. Prognostic factors in surgically treated stage IB-IIB carcinoma of the cervix with negative lymph nodes. Int. J. Gynecol. Cancer 8 (1998) 23-26
14. Lukas R., Pavel S., Helena R., Charvat M., Pluta M., Schlegerova D., et al. Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecol. Oncol. 98 (2005) 281-288
15. Levenback C., Coleman R.L., Burke T.W., Lin W.M., Erdman W., Deavers M., et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J. Clin. Oncol. 20 (2002) 688-693
16. Barranger E., Cortez A., Commo F., Marpeau O., Uzan S., Darai E., et al. Histopathological validation of the sentinel node concept in cervical cancer. Ann. Oncol. 15 (2004) 870-874
17. Echt M.L., Finan M.A., Hoffman M.S., Kline R.C., Roberts W.S., and Fiorica J.V. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med. J. 92 (1999) 204-208
18. Lin Y.S., Tzeng C.C., Huang K.F., Kang C.Y., Chia C.C., and Hsieh J.F. Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer. Int. J. Gynecol. Cancer 15 (2005) 273-277
19. Morice P., Sabourin J.C., Pautier P., Mercier S., Duvillard P., and Castaigne D. Indications and results of frozen section examination of pelvic lymph nodes in the surgical strategy of stage Ib or II cervical cancer. Ann. Chir. 53 (1999) 583-586
20. Francesco F., Manuela L., Gian F.Z., Distefano M., Fagotti A., Ceccaroni M., et al. Frozen section examination of pelvic lymph nodes in endometrial and cervical cancer: accuracy in patients submitted to neoadjuvant treatments. Gynecol. Oncol. 94 (2004) 779-784
21. Chou H.H., Chang T.C., Yen T.C., Ng K.K., Hsueh S., Ma S.Y., et al. Low value of [18F]-fluoro-2-deoxy-d-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J. Clin. Oncol. 24 (2006) 123-128
22. Van Trappen P., Gyselman V., Lowe D., Ryan A., Oram D.H., Bosze P., et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 357 (2001) 15-20
23. Kobayashi Y., Yoshinouchi M., Tianqi G., Nakamura K., Hongo A., Kamimura S., et al. Presence of human papillomavirus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes. Clin. Cancer Res. 4 (1998) 979-983
24. Hernadi Z., Szarka K., Sapy T., Krasznai Z., Veress G., and Poka R. The prognostic significance of HPV-16 genome status of the lymph nodes the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up. BJOG 110 (2003) 205-209
25. Chan P.K., Yu M.M., Cheung T.H., To K.F., Lo K.W., Cheung J.L., et al. Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma. J. Clin. Virol. 33 (2005) 201-205
26. Fule T., Csapo Z., Mathe M., Tatrai P., Laszlo V., Papp Z., et al. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Gynecol. Oncol. 100 (2005) 570-578
27. Lukaszuk K., Liss J., Wozniak I., Slwiniski W., Emerich J., and Wojcikowski C. HPV and histological status of pelvic lymph node metastasis in cervical cancer: a prospective study. J. Clin. Pathol. 57 (2004) 472-476
28. Lombard I., Vincent-Salomon A., Validire P., Zafrani B., de la Rochefordiere A., Clough K., et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J. Clin. Oncol. 16 (1998) 2613-2619
29. Schwartz S., Daling J., Shera K., Madeleine M.M., McKnight B., Galloway D.A., et al. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J. Clin. Oncol. 19 (2001) 1906-1915
30. Im S.S., Wilczynski S.P., Burger R.A., and Monk B.J. Early stage cervical cancers containing HPV type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin. Cancer Res. 9 (2003) 4145-4150
31. Sapy T., Hernadi Z., Konya J., and Lukacsko L. Poor clinical outcome in early stage cervical cancer with human papillomavirus-18 positive lymph nodes. Eur. J. Obstet. Gynecol. Reprod. Biol. 90 (2000) 93-95